Are we there yet? Recent progress in the molecular diagnosis and novel antifungal targeting of Aspergillus fumigatus and invasive aspergillosis
- PMID: 24204250
- PMCID: PMC3812002
- DOI: 10.1371/journal.ppat.1003642
Are we there yet? Recent progress in the molecular diagnosis and novel antifungal targeting of Aspergillus fumigatus and invasive aspergillosis
Conflict of interest statement
The author has declared that no competing interests exist.
Figures
References
-
- Guo YL, Chen YQ, Wang K, Qin SM, Wu C, et al. (2010) Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review. Chest 138: 817–824. - PubMed
-
- Lamoth F, Cruciani M, Mengoli C, Castagnola E, Lortholary O, et al. (2012) β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). Clin Infect Dis 54: 633–643. - PubMed
-
- Held J, Schmidt T, Thornton CR, Kotter E, Bertz H (2013) Comparison of a novel Aspergillus lateral-flow device and the Platelia galactomannan assay for the diagnosis of invasive aspergillosis following haematopoietic stem cell transplantation. Infection E-pub ahead of print. doi:10.1007/s15010-013-0472-5 - DOI - PubMed
-
- Shi LN, Li FQ, Lu JF, Kong XX, Wang SQ, et al. (2012) Antibody specific to thioredoxin reductase as a new biomarker for serodiagnosis of invasive aspergillosis in non-neutropenic patients. Clin Chim Acta 413: 938–943. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources